ORNL’s Paul Langan, associate laboratory director for Biological and Environmental Systems Science, said in welcoming remarks, “Vanderbilt is one of ORNL’s core universities, and has been instrumental in helping support the lab’s science mission throughout its history. We have many areas of mutual interest that can benefit from continued research engagements.”
The symposium featured presentations on areas of potential partnership, including virtual high-throughput screening, health systems biology, discoveries in plants that can translate to human health, and the development of new radiopharmaceutical treatments.
One area discussed for potential cooperation is the development of new pathways to deliver targeted doses of medical isotopes such as the actinium-225 ORNL produces and sells under the DOE Isotope Program. Ac-225 has demonstrated success as a highly effective therapy for certain types of metastatic cancer. Both institutions are also working on developing AI to accelerate breakthroughs for human health, ranging from predicting the success of drug delivery and efficacy at the molecular level, to identifying the genes that could lead to better treatment for addiction and other disorders.
This Oak Ridge National Laboratory news article "From AI to isotopes: Symposium brings together ORNL, Vanderbilt scientists" was originally found on https://www.ornl.gov/news
